Bad news: earnings release, analyst downgrades, CEO bad press, Evolus botox approved.
All bad news is out. Expect price to consolidate and move up from here.
Lets wait and see.
Comment:
Expect a continuation of trend.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
